April 26, 2024

• 

[THE INVESTOR] Kolmar Korea’s financial burden from taking over CJ Healthcare will be limited, said NH Investment and Securities on Feb. 22.

It will form a consortium with Mirae Asset PE, H&Q Korea and STIC Investment for the 1.3 trillion won acquisition, and its direct investment will amount to 200 billion won, estimated analyst Han Guk-heui.

Since Kolmar Korea’s debt-equity ratio is about 50 percent, with about 100 billion won EBITDA a year, borrowing 200 billion won will not be a serious burden, said the analyst. 

If there are no additional financial risks, this acquisition is positive in that it is adding a new business with strong capacity to generate cash without hurting its fundamentals, she added.

By Hwang You-mee (glamazon@heraldcorp.com)